Statins at the equator of decades. 40 years since the study of 4S

by A. V. Susekov
Published 2014-12-01

Current approaches to the treatment of dyslipidemia: from scholarly disputes to the individual patient

by A. V. Susekov
Published 2015-12-01

Low density lipoprotein cholesterol (H-LDL) and remnant non-HDL cholesterol: any reason to change the order when assessing cardiovascular risk?

by A. V. Susekov
Published 2013-12-01

Practical aspects of "Heart Protection Studies"

by A V Susekov
Published 2004-02-01

Statin therapy and atherosclerosis regression

by A. V. Susekov
Published 1970-01-01

Atorvastatin: evidence base 15 years later

by A. V. Susekov, N. V. Khokhlova
Published 2011-06-01

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE

by A. V. Susekov, N. V. Khokhlova
Published 2016-01-01

New hypolipidemic drugs from the group of reductase inhibitors GMG-CoA

by A V Susekov, M Yu Zubareva, V V Kukharchuk
Published 2003-02-01

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THER...

by A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
Published 2016-01-01

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY....

by A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
Published 2016-01-01

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the leve...

by A. V. Susekov, M. Yu. Zubareva, T. A. Rozhkova, V. P. Masenko
Published 2011-12-01

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with in...

by M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva, A. V. Susekov
Published 2010-12-01

Statin therapy and atherosclerosis stabilization in carotid arteries

by Z. G Luginova, M. V Koshurnikova, E. Yu Solovieva, T. V Balakhonova, A. V Susekov
Published 2015-03-01

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis

by A. V. Susekov, N. B. Gornyakova, M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva
Published 2009-12-01

Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment

by V. К. Zafiraki, Е. D. Kosmacheva, I. N. Zakharova, V. A. Korneva, A. V. Susekov
Published 2018-10-01

Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later

by Andrey Vladimirovich Susekov, Natal'ya Badrievna Gornyakova, Marina Yur'evna Zubareva, A V Susekov, N B Gornyakova, M Yu Zubareva
Published 2010-12-01

P2.05 ARTERIAL WALL FUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND DYSLIPIDEMIA, COMPARATIVE EFFICACY OF EZETIMIBE, STATINS AND THEIR COMBINATION

by M.I. Tripoten, O.A. Pogorelova, M.Y. Zubareva, V.V. Kukharchuk, A.N. Rogoza, A.V. Susekov, T.V. Balakhonova
Published 2010-12-01

STATINS IN PREVENTION OF ISCHEMIC STROKE

by A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
Published 2015-09-01

STATINS IN PREVENTION OF ISCHEMIC STROKE

by A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
Published 2015-09-01

Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen l...

by A. V. Susekov, M. Yu. Zubareva, M. I. Tripoten’, T. A. Rozhkova, O. A. Pogorelova, T. V. Balakhonova, V. P. Masenko, V. V. Kukharchuk
Published 2006-12-01